- Researchers report that psilocybin from mushrooms can help relieve depression for people with cancer.
- They noted that psilocybin is not a treatment for cancer but said it can help with the disposition and outlook of people with cancer.
- Psilocybin is listed as a schedule I drug by federal authorities and has not been approved for clinical use by federal officials.
Mushrooms may be more magical than previously believed.
A new study published in the journal Cancer reports that psilocybin from mushrooms may help people being treated for cancer and/or depression.
Results from a phase two clinical trial found that psilocybin – a hallucinogenic chemical found in certain types of mushrooms of the genus Psilocybe – helped trial participants. The study authors said the participants experienced fewer symptoms of depression and “spoke highly of the therapy when interviewed at the end of the trial.”
The substance is currently considered a schedule I drug by the U.S. government, currently defined as having a high potential for abuse and no accepted medical use. The Food and Drug Administration also has not approved it for clinical use.
However, the study authors said “multiple randomized controlled trials have demonstrated the safety and potential efficacy of psilocybin-assisted therapy—which combines psilocybin with psychological support from trained therapists—to treat major depressive disorder.”
They also pointed out there’s plenty of research taking place concerning using psilocybin in treating mental health conditions, including addiction, anxiety, and post-traumatic stress disorder.
The new study involved adults with cancer and depression.
In the trial, 30 people received a 25 mg dose of synthesized psilocybin, group therapy, and a one-on-one session with a therapist at Sunstone Therapies in Rockville, Maryland.
“This study was…
Read the full article here